Los Alamos County, N.M., funds by Health and Human Services, Department of
Listing $2,549,147.99 in stimulus funds from Health and Human Services, Department of for Los Alamos
Note: For some programs where states do not report where money will be distributed across the state, we do not have the allocation for individual counties. Those programs include: Medicaid, unemployment benefits and food stamps. Those amounts are included in the totals for where the state agency receiving that money is located.
Amount refers to both the amount of stimulus funding going toward the project and the face value of the loan.
| Recipient | Amount | Description | Federal Dept./Agency | Date |
|---|---|---|---|---|
| LOS ALAMOS NATIONAL SECURITY, LLC | $816,477 |
Trans-NIH Recovery Act Research Support The function of millions of proteins remains unknown, and automated protein function prediction systems have a poor record of performance. We will test hypotheses about protein functional sites by validating high-throughput predictions derived from comput
This spending item is part of a $1,432,837 allocation.
See details
|
National Institutes of Health | 5/14/2009 |
| LOS ALAMOS NATIONAL SECURITY, LLC | $730,160 | Broadly reactive human antibodies against influenza M2 for therapy and prophylaxisG? Influenza is a globally important pathogen responsible for intermittent lethal pandemics. Present vaccination strategies are mainly based on a trivalent vaccine created p | National Institutes of Health | 8/15/2009 |
| LOS ALAMOS NATIONAL SECURITY, LLC | $443,846 | Riboswitch design principles: interplay between switching, ligand binding and foldingG? Riboswitches are recently discovered powerful noncoding RNAs that turn on or off gene expression, depending on the presence of a ligand. We will use an approach that | National Institutes of Health | 8/30/2009 |
| CALDERA PHARMACEUTICALS, INC. | $178,915 | Trans-NIH Recovery Act Research Support Caldera Pharmaceuticals will complete the necessary steps to commercialize its XRflo system. In Phase I we demonstrated the feasibility of this technique to measure unlabeled protein interactions in a fluidic system. XRflo allows for real-time, direct, la | National Institutes of Health | 9/30/2009 |
| CALDERA PHARMACEUTICALS, INC. | $178,915 | Trans-NIH Recovery Act Research Support Caldera Pharmaceuticals will complete the necessary steps to commercialize its XRflo system. | National Institutes of Health | 9/30/2009 |
| LOS ALAMOS NATIONAL SECURITY, LLC | $131,665 |
Trans-NIH Recovery Act Research Support Hepatitis B Virus (HBV) infects more than 2 billion people alive today and is responsible for over 1 million deaths caused by acute and chronic hepatitis and hepatocellular carcinoma every year. Although remarkable progress has been made in understanding
This spending item is part of a $474,364 allocation.
See details
|
National Institutes of Health | 7/17/2009 |
| LOS ALAMOS NATIONAL SECURITY, LLC | $69,170 |
Trans-NIH Recovery Act Research Support Our goal is to understand the regulation of ErbB signaling in endometrial and breast cancers, diseases where amplification of ErbB genes (EGFR, ErbB2, ErbB3) is associated with poor outcome. The composition of the UNM team is unique, with expertise in sig
This spending item is part of a $611,878 allocation.
See details
|
National Institutes of Health | 7/17/2009 |